SCHEMBL5154097

SCHEMBL5154097

COC(=O)c1ccc(Cc2ccccc2)[nH]c1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.54
GAA P10253 3/20 0.54
GLA P06280 1/20 0.54
ALDH1A1 P00352 6/20 0.51
RNASEH1 O60930 1/20 0.50
TSHR P16473 2/20 0.49
MAPT P10636 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
NFKB1 P19838 1/20 0.49
CYP2C19 P33261 1/20 0.49
BLM P54132 1/20 0.49
PMP22 Q01453 1/20 0.49
HIF1A Q16665 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
HSD17B10 Q99714 2/20 0.44
USP2 O75604 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4438837 0.93 ALDH1A1 (0.49) KDM4EGAAGLAALDH1A1RNASEH1
SCHEMBL4426834 0.92 ALDH1A1 (0.54) KDM4EGAAGLAALDH1A1RNASEH1
SCHEMBL4426842 0.92 KDM4E (0.49) KDM4EGAAGLAALDH1A1RNASEH1
SCHEMBL4438532 0.88 ALDH1A1 (0.47) KDM4EGAAGLAALDH1A1RNASEH1
SCHEMBL4429436 0.87 KDM4E (0.53) KDM4EGAAGLAALDH1A1RNASEH1
SCHEMBL3913842 0.86 KDM4E (0.51) KDM4EGAAGLAALDH1A1TSHR
SCHEMBL4433934 0.86 KDM4E (0.51) KDM4EGAAGLAALDH1A1RNASEH1
SCHEMBL4428291 0.85 KDM4E (0.48) KDM4EGAAGLAALDH1A1RNASEH1
SCHEMBL4428809 0.84 DAO (0.48) KDM4EGAAGLAALDH1A1MAPT
SCHEMBL4430805 0.84 KDM4E (0.47) KDM4EGAAGLAALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3814330-A1 IMMUNOMODULATORY COMPOUNDS Dana-Farber Cancer Institute, Inc. (US) 2021-05-05 EP disclosed
EP-1737451-A2 MONOCYCLIC HETEROCYCLES AS KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2007-01-03 EP disclosed
WO-2005117867-A2 MONOCYCLIC HETEROCYCLES AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-12-15 WO disclosed